Literature DB >> 15956173

Anti-MuSK myasthenia gravis presenting with purely ocular findings.

James B Caress1, Christopher H Hunt, Sat Dev Batish.   

Abstract

BACKGROUND: Antibodies to a muscle-specific receptor tyrosine kinase (MuSK) have been found in approximately 40% of patients with generalized myasthenia gravis who are seronegative for the antiacetylcholine receptor antibody. Many of the patients with anti-MuSK antibodies have prominent oculobulbar symptoms or weakness of the neck and respiratory muscles, but patients with ocular myasthenia have not been described.
OBJECTIVE: To report a case of ocular myasthenia due to anti-MuSK antibodies. PATIENT: A young woman with ocular myasthenia and antibodies to MuSK.
RESULTS: Anti-MuSK antibody was detected by radioimmunoassay using highly purified MuSK recombinant antigen.
CONCLUSION: Ocular myasthenia gravis is a presentation of the anti-MuSK antibody syndrome.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15956173     DOI: 10.1001/archneur.62.6.1002

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  11 in total

1.  MuSK-antibody positive pure ocular myasthenia gravis.

Authors:  Frank Hanisch; Katharina Eger; Stephan Zierz
Journal:  J Neurol       Date:  2005-11-29       Impact factor: 4.849

2.  Ocular myasthenia: a rare presentation with MuSK antibody and bilateral extraocular muscle atrophy.

Authors:  Jane W Chan; William W Orrison
Journal:  Br J Ophthalmol       Date:  2007-06       Impact factor: 4.638

3.  Anti-MuSK antibodies in a case of ocular myasthenia gravis.

Authors:  D L H Bennett; K R Mills; P Riordan-Eva; P R J Barnes; M R Rose
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-04       Impact factor: 10.154

Review 4.  Anti-MuSK ocular myasthenia with extrinsic ocular muscle atrophy: a new clinical phenotype?

Authors:  Dario Ricciardi; Vincenzo Todisco; Gioacchino Tedeschi; Giovanni Cirillo
Journal:  Neurol Sci       Date:  2019-08-17       Impact factor: 3.307

Review 5.  Muscle-Specific Tyrosine Kinase and Myasthenia Gravis Owing to Other Antibodies.

Authors:  Michael H Rivner; Mamatha Pasnoor; Mazen M Dimachkie; Richard J Barohn; Lin Mei
Journal:  Neurol Clin       Date:  2018-05       Impact factor: 3.806

Review 6.  Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity.

Authors:  Matthew N Meriggioli; Donald B Sanders
Journal:  Lancet Neurol       Date:  2009-05       Impact factor: 44.182

7.  Ocular myasthenia gravis: controversies and updates.

Authors:  Sui H Wong; Saif Huda; Angela Vincent; Gordon T Plant
Journal:  Curr Neurol Neurosci Rep       Date:  2014-01       Impact factor: 5.081

8.  Comparison of muscle ultrastructure in myasthenia gravis with anti-MuSK and anti-AChR antibodies.

Authors:  Giovanna Cenacchi; Valentina Papa; Papa Valentina; Marina Fanin; Fanin Marina; Elena Pegoraro; Pegoraro Elena; Corrado Angelini; Angelini Corrado
Journal:  J Neurol       Date:  2010-11-19       Impact factor: 4.849

9.  Stable expression of human muscle-specific kinase in HEp-2 M4 cells for automatic immunofluorescence diagnostics of myasthenia gravis.

Authors:  Sandra George; Silvia Paulick; Ilka Knütter; Nadja Röber; Rico Hiemann; Dirk Roggenbuck; Karsten Conrad; Jan-Heiner Küpper
Journal:  PLoS One       Date:  2014-01-09       Impact factor: 3.240

10.  Muscle-specific receptor tyrosine kinase antibody positive myasthenia gravis current status.

Authors:  Shin Joong Oh
Journal:  J Clin Neurol       Date:  2009-06-30       Impact factor: 3.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.